Overview
Devjanee (Devi) Swain Lenz, PhD, is the Director of the Duke Sequencing and Genomics Technologies Core Facility (SGT) and has over 15 years of experimental and computational experience in genomics research. She earned her PhD in Molecular Genetics and Genomics at Washington University in St. Louis and completed her postdoctoral research at Duke University. Her research interests focus on understanding how cis-regulatory variation contributes to phenotypic differences between and within species. She has also held multiple leadership roles for nonprofit organizations whose emphasis is on increasing and maintaining diversity, equity, and inclusion in STEM-related fields.
If you are interested in working with the SGT, you can find more information on our website or schedule a consultation.
Current Appointments & Affiliations
Recent Publications
A platform-agnostic evaluation of non-formalin fixed single cell RNA technologies
Preprint · January 28, 2026 Full text CiteGranuloma dual RNA-seq reveals composite transcriptional programs driven by neutrophils and necrosis within tuberculous granulomas.
Journal Article Sci Adv · January 23, 2026 Mycobacterial granulomas lie at the center of tuberculosis (TB) pathogenesis and represent a unique niche where infecting bacteria survive under nutrient-restricted conditions and in the face of a host immune response. The granuloma's necrotic core, where ... Full text Link to item CiteRecent Grants
Advancing a Holistic Understanding of Variability in Lived Experience with Sickle Cell Pain
ResearchCo Investigator · Awarded by National Institutes of Health · 2025 - 2030Developing strategies to identify candidate individuals for early genetic therapies
ResearchCollaborator · Awarded by Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2024 - 2029Novel molecular mechanisms of organ crosstalk and kidney injury from inhaled silica.
ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2028View All Grants